CA3116952A1 - Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique - Google Patents

Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique Download PDF

Info

Publication number
CA3116952A1
CA3116952A1 CA3116952A CA3116952A CA3116952A1 CA 3116952 A1 CA3116952 A1 CA 3116952A1 CA 3116952 A CA3116952 A CA 3116952A CA 3116952 A CA3116952 A CA 3116952A CA 3116952 A1 CA3116952 A1 CA 3116952A1
Authority
CA
Canada
Prior art keywords
extract
algae
ulva
cells
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3116952A
Other languages
English (en)
French (fr)
Inventor
Karim Asehnoune
Cedric Jacqueline
Marwan BOURAS
Antoine ROQUILLY
Pi Nyvall-Collen
Herve Demais
Herve Balusson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amadeite SAS
Original Assignee
Amadeite SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amadeite SAS filed Critical Amadeite SAS
Publication of CA3116952A1 publication Critical patent/CA3116952A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA3116952A 2018-10-22 2019-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique Pending CA3116952A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1859721A FR3087338B1 (fr) 2018-10-22 2018-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
FR1859721 2018-10-22
PCT/EP2019/078757 WO2020083931A1 (fr) 2018-10-22 2019-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique

Publications (1)

Publication Number Publication Date
CA3116952A1 true CA3116952A1 (fr) 2020-04-30

Family

ID=65494363

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3116952A Pending CA3116952A1 (fr) 2018-10-22 2019-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique

Country Status (10)

Country Link
US (1) US12377126B2 (https=)
EP (2) EP3870198B1 (https=)
JP (1) JP7614105B2 (https=)
KR (1) KR102922546B1 (https=)
CN (1) CN113347984A (https=)
AU (2) AU2019364677B2 (https=)
CA (1) CA3116952A1 (https=)
FR (1) FR3087338B1 (https=)
IL (1) IL282511B1 (https=)
WO (1) WO2020083931A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114376233A (zh) * 2022-03-23 2022-04-22 青岛海大生物集团股份有限公司 一种具有增强免疫功能的浒苔多糖保健食品及制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132101B2 (en) 2002-02-27 2006-11-07 Duquesne University Of The Holy Ghost Compositions and methods for eliciting an immune response to gram-negative bacterial infections
NZ542791A (en) 2003-04-08 2008-04-30 Biotempt Bv Compositions for mucosal and oral administration comprising HCG fragments
RU2417093C2 (ru) 2005-06-24 2011-04-27 Дезерт Лейк Текнолоджиз Очищенный компонент цианобактерий и способ применения
ATE514950T1 (de) 2007-09-07 2011-07-15 Univ Zuerich Verfahren zur untersuchung von sepsis bei menschen
KR101102829B1 (ko) * 2008-09-12 2012-01-05 재단법인 제주테크노파크 구멍갈파래 추출물과 그것의 항염증제로서의 용도
US9370537B2 (en) * 2009-04-03 2016-06-21 Cerule, Llc Compositions and methods for reducing inflammation
FR2954703B1 (fr) * 2009-12-28 2013-12-13 Chu Nantes Agonistes des recepteurs tlr 4 et 9 pour prevenir les complications septiques de l'immunodepression post-traumatique chez les patients hospitalises pour traumatismes severes
US20130102662A1 (en) * 2011-06-09 2013-04-25 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of inducible nitric oxide synthase inhibitors and nitric oxide scavengers to inhibit post-traumatic immunodepression
FR2999084B1 (fr) * 2012-12-11 2015-03-13 Amadeite Extrait d'algues comprenant en particulier des polysaccharides polyanioniques sulfates et non sulfates et ses applications
FR3013223B1 (fr) * 2013-11-18 2016-09-02 Amadeite Extrait d'algues pour son utilisation en tant qu'agent anti-bacterien
FR3013222B1 (fr) * 2013-11-18 2016-09-30 Amadeite Extrait d'algues pour son utilisation en tant qu'agent immunomodulateur

Also Published As

Publication number Publication date
US20210386808A1 (en) 2021-12-16
US12377126B2 (en) 2025-08-05
AU2019364677A1 (en) 2021-05-20
KR102922546B1 (ko) 2026-02-04
AU2025200105A1 (en) 2025-01-23
BR112021007506A2 (pt) 2021-07-27
IL282511A (en) 2021-06-30
JP2022508900A (ja) 2022-01-19
WO2020083931A1 (fr) 2020-04-30
EP4483961A3 (fr) 2025-03-19
EP4483961A2 (fr) 2025-01-01
FR3087338B1 (fr) 2020-10-09
EP3870198C0 (fr) 2024-11-20
EP3870198A1 (fr) 2021-09-01
JP7614105B2 (ja) 2025-01-15
KR20210114921A (ko) 2021-09-24
IL282511B1 (en) 2026-02-01
EP3870198B1 (fr) 2024-11-20
FR3087338A1 (fr) 2020-04-24
AU2019364677B2 (en) 2024-10-10
CN113347984A (zh) 2021-09-03

Similar Documents

Publication Publication Date Title
EP3369425B1 (en) Compositions comprising bacterial strains
KR101629525B1 (ko) 발효식품에서 유래된 세포밖 소포체를 포함하는 조성물 및 이의 용도
KR20130021920A (ko) Ａｋｋｅｒｍａｎｓｉａ ｍｕｃｉｎｉｐｈｉｌａ 또는 Ｂａｃｔｅｒｏｉｄｅｓ ａｃｉｄｉｆａｃｉｅｎｓ 유래 세포밖 소포체를 유효성분으로 함유하는 염증성 질환의 치료 또는 예방용 조성물
TW202011975A (zh) 包含細菌菌株之組合物
FR2962045A1 (fr) Complexe macromoleculaire d'origine bacterienne et utilisation dudit complexe moleculaire pour prevenir et traiter les rhumatismes inflammatoires
CN106163533A (zh) 免疫平衡调节剂
WO2024219483A1 (ja) 歯周病菌用増殖抑制剤、およびその用途
WO2007132900A1 (ja) 皮膚保湿剤および皮膚炎治療剤
EP3870198B1 (fr) Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
TW201707723A (zh) 抗微生物胜肽用於治療胃潰瘍的用途
JP2013521302A (ja) ミリスチン酸を含む組成物およびその使用
WO2017125417A1 (en) Tofacitinib as vaccination immune modulator
CA3012894C (fr) Souche bacterienne comme agents de prevention et/ou de traitement de pathologies respiratoires
JP2022508900A5 (https=)
EP3947747A1 (fr) Traitement des maladies respiratoires avec une bacterie du genre lactobacillus
US20170152285A1 (en) Extracting method of kuguacin, pharmaceutical composition comprising the kuguacin and use thereof
JP7313440B2 (ja) Ｔｒｅｇ細胞を誘導する酵母由来多糖体の構造及び機能特性
BR112021007506B1 (pt) Uso de um extrato de algas verdes do tipo ulva
HK1260125B (en) Compositions comprising bacterial strains
Krauss ‘Complementary’immune evasion by oral pathogen Porphyromonas gingivalis
JP2001335507A (ja) 抗癌組成物

Legal Events

Date Code Title Description
D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED

Effective date: 20240920

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20240920

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240925

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240925

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240925

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20241205

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250416

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20250430

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250922

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250922